XNCR

33.2602.21%
JR

John R. Desjarlais

Executive VP of Research & Chief Scientific Officer

Dr. John R. Desjarlais, Ph.D., has been Executive Vice President and Chief Scientific Officer at Xencor, Inc. since April 2023 and July 15, 2014 respectively and had been its Senior Vice President of Research since March 2016 until 2023. Dr. Desjarlais oversees all aspects of discovery and research at Xencor, Inc., including technology development, protein and antibody engineering and generation of drug candidates. He has driven Xencor, Inc.'s technology development and engineering efforts for over 5 years and participated in the business development and intellectual property strategies. Dr. Desjarlais was a Vice President of Research at Xencor, Inc. since October 2006 until July 15, 2014. He joined the Xencor, Inc. in July 2001, initially serving as Director of Protein Engineering. Prior to Xencor, Dr. Desjarlais served as an Assistant Professor of Chemistry at Penn State University from 1997 to 2001, where he developed protein engineering methods similar to Xencor's PDA® technology platform. Dr. Desjarlais studied BS in Physics from the University of Massachusetts and a Ph.D. in Biophysics from Johns Hopkins University. He then conducted postdoctoral research at the University of California, Berkeley.

Positions